The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.

Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new medicine remains unabated, but the cost and need to bring those to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.

Request a Sample for or Inquire before buying the report @ 

http://www.reportsnreports.com/reports/143450-outsourcing-in-drug-development-the-contract-research-clinical-trial-market.html

Kalorama Information's Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing  medicine development, the companies involved in this market and the opportunity for revenues.

As part of its comprehensive coverage of this market, this report contains:

• A Detailed Introduction to the Clinical Trial Process
• How CROs are Meeting the Challenge of Patient Recruitment
• Discussion of Industry and Regulatory Trends Protocols Funded in FY2009 by Percent and Gender
• Global R&D Expenditures Outsourced by Percent 2003-2010
• Selected Pharmaceutical Company Acquisitions, 2009-2011
• Top Ten Therapeutic Categories in R&D
• Selected Acquisitions of Leading CROs
• Increasing role of EDCs
• Directory of Companies
• Market Share of Major CROs 2011
• Profiles of CROs, Contract Laboratories, Clinical Trial Labs and EDC Solution Companies

As part of Kalorama Information's research process, information for this report is gathered from sources including trade press, company reports and government databases. Kalorama Information's analyst also interviewed dozens of experts in the industry to discover new trends and confirm assumptions.
Explore Comprehensive list of more than 235 Tables & Figures available in the report Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market